Consumer perceptions of prescription drug websites: A pilot study

Health Marketing Quarterly

Volumn 27, Issue 2, 2010, Pages 173-194

  Wymer, Walter ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Information processing; Pharmaceutical marketing; Prescription drug websites; Young adult consumers

Indexed keywords

ADULT; ARTICLE; CONSUMER; FEMALE; FINANCIAL MANAGEMENT; HUMAN; INTERNET; MALE; PERCEPTION; PHARMACY; PILOT STUDY; QUESTIONNAIRE; UNITED STATES;

CONSUMER SATISFACTION; FEMALE; HUMANS; INTERNET; MALE; MARKETING OF HEALTH SERVICES; PERCEPTION; PHARMACEUTICAL SERVICES; PILOT PROJECTS; QUESTIONNAIRES; UNITED STATES; YOUNG ADULT;

EID: 77951992430     PISSN: 07359683     EISSN: 15450864     Source Type: Journal    
DOI: 10.1080/07359681003745139     Document Type: Article

References (79)

1. Abramson, J. (2004). Overdo$ed America: The broken promise of American medicine. New York: HarperCollins.
2. Angell, M. (2004). The truth about drug companies: How they deceive us and what to do about it. New York: Random House.
3. Aikin, K. (2002). Direct to consumer advertising of prescription drugs, 1999-2002: Preliminary patient survey results (Research report). Silver Spring, MD: Division of Drug Marketing, Advertising, and Communications, Food and Drug Administration.
4. Alperstein, N., & Peyrot, M. (1993). Consumer awareness of prescription drug adver-tising. Journal of Advertising Research, 33(4), 50-56.
5. Bailey, J. (2006). Advertising of pharmaceuticals. International Debate Education Association. Retrieved from http://www.idebate.org/debatabase/topic_details.php?topicID=528
6. Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999). Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14, 651-657.
7. Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (2000). Direct-to-consumer prescription drug advertising 1989-1998: A content analysis of conditions, targets, induce- ments, and appeals. Journal of Family Practice, 49, 329-335.
8. Barlett, D. L., Steele, J. B., Karmatz, L., Kiviat, B., & Levinstein, J. (2004, February 2). Why we pay so much for drugs. Time, 45-52.
9. Blank, C. (2006). Pharmaceutical marketing shifts online. DM News. Retrieved from www.dmnews.com/cms/dmsectors/healthcare/36944.html
10. Botti, S., & Ivengar, S. S. (2006). The dark side of choice: When choice impairs social welfare. Journal of Public Policy & Marketing, 25(1), 24-38.
11. Bush, G. W. (2000). October 17, 2000 debate transcript. Commission on Presidential Debates. Retrieved from http://www.debates.org/index.php?page=october-17-2000-debate-transcript
12. Calfee, John E. (2002). Public policy issues in direct-to-consumer advertising of pre- scription drugs. Journal of Public Policy and Marketing, 21(2), 174-193.
13. Carlat, D. (2006, May 9). Generic smear campaign. New York Times. Retrieved from http://www.nytimes.com/2006/05/09/opinion/09carlat.html?r=1
14. Cauchon, D. (2000, September 25). FDA advisors tied to industry. USA Today, 1A.
15. Clark, K. (2003). Customer disservice: These days, you're not always right. But you are always cranky and confused. Here's why. U.S. News & World Report, 135(5), 29-32.
16. Cohen, J. B. (2002). Introductory comments: Direct-to-consumer prescription drug advertising: Evaluating regulatory policy in the United States and New Zealand. Journal of Public Policy & Marketing, 21, 172-173.
17. Colyer, E. (2003). Taking advantage of women. Brandchannel. Retrieved from http://www.brandchannel.com/features_effect.asp?pf_id=181
18. Coney, S. (2002). Direct-to-consumer advertising of prescription pharmaceuticals: A Consumer perspective from New Zealand. Journal of Public Policy & Marketing, 21, 213-223.
19. Cunningham, D. J., & Iyer, R. (2005). Does DTC mean "direct to court"? The Journal of Consumer Marketing, 22, 412-420.
20. DeLorme, D. E., Huh, J., & Reid, L. N. (2006). Perceived effects of direct-to-consumer (DTC) prescription drug advertising on self and others. Journal of Advertising, 35(3), 47-65.
21. Drummy, W. M., Jr. (2002). A fine line: Until regulators decide whether pharma web- sites are ads or labels, marketers must strive to maintain fair balance. Pharma- ceutical Executive. Retrieved from http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=33813
22. Dickinson, J. G. (2002, June). DTC report: FDA survey data supports DTC. Medical Marketing & Media, 32, 34.
23. Donohue, J. M., & Berndt, E. R. (2004). Effects of direct-to-consumer advertising on medication choice: The case of antidepressants. Journal of Public Policy & Marketing, 23(2), 15-127.
24. Edwards, J. (2006, September 27). New rules: Public weighs in with pharma lobby group. Brandweek. Retrieved from http://www.brandweek.com/bw/news/pharmaceutical/article_display.jsp?vnu_content_id=1003187364
25. FDA study supports DTC ads. (2003, January 27). Broadcasting & Cable, 19.
26. Fetto, J. (2002). Drugged out. American Demographics, 24(5), 11.
27. Findlay, S. (2001). Direct-to-consumer promotion of prescription drugs: Economic implications for patients, payers, and providers. Pharmacoeconomics, 19, 109-119.
28. Generation Y. (2006). Trends and problems among Generation Y members. Wikipedia. Retrieved from http://en.wikipedia.org/wiki/Generation_Y
29. Goetzl, D., Klaassen, A., Teinowitz, I., & Sanders, L. (2001). Dose of reality. Advertising Age, 72(30), 1-2.
30. Heather, J. L. (2001). Liability for direct-to-consumer advertising and drug information on the internet. Defense Counsel Journal, 68, 412-420.
31. Holdford, D. (2005). Understanding the dynamics of the pharmaceutical market using a social marketing framework. Journal of Consumer Marketing, 22(7), 388-396.
32. Kaiser Public Opinion Spotlight. (2005). Views on prescription drugs and the phar-maceutical industry. Retrieved from www.kff.org/spotlight/rxdrugs/index.cfm
33. Kerber, R. (2005, August 18). Doctors criticize sleeping-pill ads Sepracor's claims about drug misleading, psychiatrists say. Boston Globe. Retrieved from http://www.boston.com/business/globe/articles/2005/08/18/doctors_criticize_sleeping_pill_ads?mode=PF
34. Kopp, S. W., & Bang, H.-K. (2000). Benefit and risk information in prescription drug advertising: Review of empirical studies and marketing implications. Health Marketing Quarterly, 17(3), 39-56.
35. Kopp, S. W., & Sheffet, M. J. (1997). The effect of direct-to-consumer advertising of prescription drugs on retail gross margins: Empirical evidence and public policy implications. Journal of Public Policy & Marketing, 16, 270-276.
36. Lexchin, J., & Mintzes, B. (2002). Direct-to-consumer advertising of prescription drugs: The evidence says no. Journal of Public Policy & Marketing, 21, 194-201.
37. Macias, W., & Lewis, L. S. (2003). A content analysis of direct-to-consumer (DTC) prescription drug websites. Journal of Advertising, 32(4), 43-57.
38. Macias, W., & Lewis, L. S. (2005). How well do direct-to-consumer (DTC) prescrip- tion drug websites meet FDA guidelines and public policy concerns? Health Marketing Quarterly, 22(4), 45-71.
39. Maddox, L. M. (1999). The use of pharmaceutical websites for prescription drug information and product requests. The Journal of Product and Brand Manage- ment, 8, 488-501.
40. Manish, S. S., Holmes, E. R., & Desselle, S. P. (2003). The use of persuasion in print DTC advertisements of prescription drugs: A content analysis of leading con- sumer magazines from 1995-2000. Journal of Pharmaceutical Marketing & Management, 15(3), 23-43.
41. Martin, C. A. (2001). Managing Generation Y. Amherst, MA: HRD Press.
42. Mascarenhas, O., Kesavan, R., & Bernacchi, M. (2005). Global marketing of lifesaving drugs: An analogical model. Journal of Consumer Marketing, 22(7), 404-411.
43. Mason, M. J. (1998). Drugs or dietary supplements: FDA's enforcement of DSHEA. Journal of Public Policy & Marketing, 17, 296-302.
44. McKillen, D. (2003, February). Web watch. Medical Marketing and Media, 30-31.
45. Menon, A. M., Deshpande, A. D., Perri, M. III, & Zinkhan, G. M. (2002). Trust in online prescription drug information among Internet users: The impact on infor-mation search behavior after exposure to direct-to-consumer advertising. Health Marketing Quarterly, 20(1), 17-32.
46. Menon, A. M., Deshpande, A. D., Perri, M. III, & Zinkhan, G. M. (2003). Consumers' attention to the brief summary in print direct-to-consumer advertisements: Perceived usefulness in patient-physician discussions. Journal of Public Policy & Marketing, 22(2), 181-191.
47. Miller, T. E., & Rents, S. (1998). The health-care industry in transition: The online mandate to change. New York: Cyber Dialog, Inc.
48. Mintzes, B. (1998). Blurring the boundaries: New trends in drug promotion. Amsterdam, The Netherlands: Health Action International (HAI-Europe).
49. Mintzes, B. (2001). Direct-to-consumer prescription drug advertising: The European Commission's proposals for legislative change. Amsterdam, The Netherlands: Health Action International (HAI-Europe).
50. Morris, L. A., Mazis, M. B., & Brinberg, D. (1989). Risk disclosures in televised pre- scription drug advertising to consumers. Journal of public Policy & Marketing, 8(1), 64-80.
51. Morris, L. A., Tabak, E. R., & Olins, N. J. (1992). A segmentation analysis of prescrip- tion drug information-seeking motives among the elderly. Journal of Public Policy & Marketing, 11(2), 15-125.
52. Murray, J. A. (1986). Post-marketing surveillance in pharmaceuticals: Reactions. Journal of Public Policy & Marketing, 5(1), 44-60.
53. NAS. (2006). Generation Y: The Millennials-ready or not, here they come. Retrieved from http://www.nasrecruitment.com/docs/white_papers/Generation-Y.pdf
54. Nearing, M. (1998). Health care moves online: Drug company websites are booming as consumers turn to them for information. Marketing, 103(39), 26-27.
55. Oser, K. (2006, August 16). Pharmaceutical spending expected to reach $1.3 billion. Retrieved from http://www.emarketer.com/Article.aspx?1004120
56. Peyrot, M., Alperstein, N. M., Van Doren, D., & Poli, L. G. (1998). Direct-to-consumer ads can influence behavior. Marketing Health Services, 18(2), 27-32.
57. Pines, W. L. (1999). A history and perspective on direct-to-consumer promotion. Feed and Drug Law Journal, 54, 489-518.
58. Pinto, M. B., Pinto, J. K., & Barber, J. C. (1998). The impact of pharmaceutical direct advertising: Opportunities and obstructions. Health Marketing Quarterly, 15(4), 89-101.
59. Rosenthal, M. B, Berndt, E. R., Donohue, J. M., Epstein, A. M., & Frank, R. G. (2003). Demand effects of recent changes in prescription drug promotion. In D. M. Cutler & A. M. Garber (Eds.), Frontiers in health policy research (Vol. 6, pp. 1-26). Cambridge, MA: MIT Press.
60. Rotfeld, H. (2005). For the drugs we need. The Journal of Consumer Marketing, 22(7), 365-370.
61. Roth, M. S. (1996). Patterns in direct-to-consumer prescription drug print advertising and their public policy implications. Journal of Public Policy & Marketing, 15(1), 63-75.
62. Rucker, D. D., & Petty, R. E. (2006). Increasing the effectiveness of communications to consumers: Recommendations based on elaboration likelihood and attitude certainty perspectives. Public Policy & Marketing, 25(1), 39-54.
63. Scussa, F. (2001). Getting noticed: The future of consumer promotion is being challenged by government agencies and the public. Med Ad News, 20(6), 40-45.
64. Sheehan, K. B. (2003). Balancing acts: An analysis of Food and Drug Administration letters about direct-to-consumer advertising violations. Journal of Public Policy & Marketing, 22, 159-169.
65. Sheehan, K. B. (2005). In poor health: An assessment of privacy policies at direct-to- consumer websites. Journal of Public Policy & Marketing, 24, 273-283.
66. Sheth, J. N., & Sisodia, R. S. (2005). A dangerous divergence: Marketing and society. Journal of Public Policy & Marketing, 24(1), 161-162.
67. Shin, J., & Moon, S. (2005). Direct-to-consumer prescription drug advertising: Concerns and evidence on consumers' benefit. Journal of Consumer Marketing, 22(7), 397-403.
68. Tanouye, E. (2000, January 19). U.S. develops expensive habit with drug sector growth spurt. The Wall Street Journal Interactive Edition. Retrieved from http://www.oralchelation.com/viewpoint/others/article1.htm#1
69. Thomaselli, R. (2003, November 10). Web thrives as DTC platform. Advertising Age, 74(45), 21-24.
70. Thomaselli, R. (2006, October 23). Record year: Pharma outlay could reach $5B. Advertising Age, 77(43), 8.
71. U.S. Food and Drug Administration. (1997, August 12). Draft Guidance for Industry: Consumer-Directed Broadcast Advertisements (Federal Register, 62, No. 155, Docket No. 97D-0320, 43171-43173). Rockville, MD: Center for Drug Evaluation and Research.
72. U.S. Food and Drug Administration. (1999, August 9). Guidance for industry: Consumer-directed broadcast advertisements (Federal Register, 64 [152], 43197-98, Docket 97D-0302). Rockville, MD: Center for Drug Evaluation and Research. Retrieved from http://www.ftc.gov/os/2004/05/040512dtcdrugscomment.pdf
73. U.S. Food, and Drug Administration. (2002). FDA: The nation's premier consumer protection and health agency. Retrieved from http://hzportal.dayton.lib.oh.us/ipac20/ipac.jsp?session=1253Q8K7164C3.869852&profile=ger&uri=link=3100036~!1560284~!3100001~!3100002&aspect=subtab13&menu=search&ri=1&source=~!horizon&term=Nation%27s+premier+consumer+protection+and+health+agency&index=PALLTI
74. U.S. Food, and Drug Administration. (2004). Guidance for industry: Brief summary: Disclosing risk information in consumer-directed print advertisements. Retrieved from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm069984.pdf
75. Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association, 283, 373-380.
76. Wolfe, S. M. (2002). Direct-to-consumer advertising: Education or emotion promotion. New England Journal of Medicine, 346, 524-526.
77. Woloshin, S., Schwartz, L. M., Tremmel, J., & Welch, H. G. (2001). Direct-to- consumer advertising for prescription drugs: What are Americans being sold? The Lancet, 358, 1141-1146.
78. Wray, D. (2004). Driving efficient DTC online: A marketer's toolkit. DTC Perspectives, 3(1), 62-66.
79. Wymer, W. (2005, September/October). Pharmaceutical marketing and social contracts in America. Proceedings of the 2005 Atlantic Marketing Association Annual Conference, Salem, MA.